Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 2

1(11.1%)

9Total

N/A(8)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06494176Not ApplicableActive Not Recruiting

Virtual Reality Exposure for Dental Fear

Role: collaborator

NCT03414372Not ApplicableCompleted

Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)

Role: collaborator

NCT03601312Not ApplicableCompleted

Randomized Controlled Trial of Standard ERP and OC-Go

Role: collaborator

NCT05111938Not ApplicableCompleted

Friends, Family & Food: Food Allergy App for Youth - II

Role: collaborator

NCT03126305Completed

Initial Development and Dissemination of OC-Go

Role: collaborator

NCT03269370Not ApplicableCompleted

Family-Focused CBT Skills App and Standard Self Help Options for Childhood Anxiety

Role: collaborator

NCT02921841Not ApplicableCompleted

Digital Star: HIV Prevention for Youth in Mental Health Treatment

Role: collaborator

NCT02816684Phase 2Completed

Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety

Role: collaborator

NCT02836132Not ApplicableUnknown

Experience Success: Virtual Reality Skills Training to Enhance e-Weight Loss

Role: collaborator

NCT02379949Not ApplicableCompleted

Virtual Reality Exposure Therapy for the Treatment of Social Phobia

Role: collaborator

All 10 trials loaded